Ondine Biomedical Valuation
| OBI Stock | 11.25 0.75 6.25% |
At this time, the company appears to be overvalued. Ondine Biomedical holds a recent Real Value of USD9.11 per share. The prevailing price of the company is USD11.25. Our model determines the value of Ondine Biomedical from analyzing the company fundamentals such as Return On Equity of -6.86, current valuation of 49.25 M, and Price To Book of 4,706 X as well as examining its technical indicators and probability of bankruptcy.
Price Book 4.7 K | Enterprise Value 49.2 M | Enterprise Value Ebitda (0.43) | Price Sales 30.4341 | Enterprise Value Revenue 54.1848 |
Overvalued
Today
Please note that Ondine Biomedical's price fluctuation is slightly risky at this time. Calculation of the real value of Ondine Biomedical is based on 3 months time horizon. Increasing Ondine Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Ondine stock is determined by what a typical buyer is willing to pay for full or partial control of Ondine Biomedical. Since Ondine Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ondine Stock. However, Ondine Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 11.25 | Real 9.11 | Hype 11.25 | Naive 10.88 |
The real value of Ondine Stock, also known as its intrinsic value, is the underlying worth of Ondine Biomedical Company, which is reflected in its stock price. It is based on Ondine Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ondine Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ondine Biomedical helps investors to forecast how Ondine stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ondine Biomedical more accurately as focusing exclusively on Ondine Biomedical's fundamentals will not take into account other important factors: Ondine Biomedical Cash |
|
Ondine Biomedical Total Value Analysis
Ondine Biomedical is now forecasted to have takeover price of 49.25 M with market capitalization of 49.73 M, debt of 541 K, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ondine Biomedical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
49.25 M | 49.73 M | 541 K |
Ondine Biomedical Investor Information
About 43.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Ondine Biomedical had not issued any dividends in recent years. Ondine Biomedical is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Ondine Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ondine Biomedical has an asset utilization ratio of 20.98 percent. This indicates that the Company is making USD0.21 for each dollar of assets. An increasing asset utilization means that Ondine Biomedical is more efficient with each dollar of assets it utilizes for everyday operations.Ondine Biomedical Ownership Allocation
Ondine Biomedical owns a total of 442.04 Million outstanding shares. Ondine Biomedical has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Ondine Biomedical Profitability Analysis
The company reported the revenue of 1.2 M. Net Loss for the year was (14.41 M) with profit before overhead, payroll, taxes, and interest of 981 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ondine Biomedical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ondine Biomedical and how it compares across the competition.
About Ondine Biomedical Valuation
The stock valuation mechanism determines Ondine Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Ondine Biomedical. We calculate exposure to Ondine Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ondine Biomedical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 632.7 K | 443.9 K |
Complementary Tools for Ondine Stock analysis
When running Ondine Biomedical's price analysis, check to measure Ondine Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ondine Biomedical is operating at the current time. Most of Ondine Biomedical's value examination focuses on studying past and present price action to predict the probability of Ondine Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ondine Biomedical's price. Additionally, you may evaluate how the addition of Ondine Biomedical to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |